PIM
Platinum Investment Management Portfolio holdings
AUM
$1.5B
This Quarter Return
+5.79%
1 Year Return
+16.62%
3 Year Return
+100.57%
5 Year Return
+187.54%
10 Year Return
+422.09%
AUM
$2.88B
AUM Growth
+$2.88B
(+0.08%)
Cap. Flow
-$26.8M
Cap. Flow
% of AUM
-0.93%
Top 10 Holdings %
Top 10 Hldgs %
54.74%
Holding
161
New
15
Increased
43
Reduced
42
Closed
18
Top Buys
| 1 |
Baxter International
BAX
|
$67.7M |
| 2 |
RH
RH
|
$64.4M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
$56M |
| 4 |
Pinduoduo
PDD
|
$49.7M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$29.9M |
Top Sells
| 1 |
GE Aerospace
GE
|
$73.7M |
| 2 |
Suncor Energy
SU
|
$58.1M |
| 3 |
Micron Technology
MU
|
$51.8M |
| 4 |
LGI Homes
LGIH
|
$32.4M |
| 5 |
RXDX
Prometheus Biosciences, Inc. Common Stock
RXDX
|
$24.8M |
Sector Composition
| 1 | Technology | 18.16% |
| 2 | Industrials | 16.21% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Healthcare | 13.64% |
| 5 | Financials | 13.53% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Immunovant
IMVT
$2.91B
| $6.24M | 0.22% |
328,842
-18,128
| -5% | -$344K |
|
52
908 Devices
MASS
$199M
| $6.01M | 0.21% |
875,447
| – | – |
|
|
INBX
53
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $5.95M | 0.21% |
229,036
+6,827
| +3% | +$177K |
|
54
Cogent Biosciences
COGT
$1.83B
| $5.65M | 0.2% |
477,080
| – | – |
|
|
OMGA
55
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
| $4.97M | 0.17% |
888,335
-34,956
| -4% | -$196K |
|
56
Esperion Therapeutics
ESPR
$490M
| $4.82M | 0.17% |
3,469,634
+889,059
| +34% | +$1.24M |
|
57
Arcus Biosciences
RCUS
$1.24B
| $4.72M | 0.16% |
232,612
| – | – |
|
58
Moderna
MRNA
$9.36B
| $4.63M | 0.16% |
38,126
| – | – |
|
|
NSTG
59
DELISTED
NanoString Technologies, Inc.
NSTG
| $4.52M | 0.16% |
1,116,392
-113,411
| -9% | -$459K |
|
60
Match Group
MTCH
$9.04B
| $4.51M | 0.16% |
107,826
| – | – |
|
|
SAGE
61
DELISTED
Sage Therapeutics
SAGE
| $4.32M | 0.15% |
91,933
+16,013
| +21% | +$753K |
|
62
Merus
MRUS
$5.04B
| $3.96M | 0.14% |
150,238
-88,814
| -37% | -$2.34M |
|
63
AC Immune
ACIU
$227M
| $3.91M | 0.14% |
1,322,462
+240,000
| +22% | +$709K |
|
64
Zai Lab
ZLAB
$3.48B
| $3.74M | 0.13% |
134,783
| – | – |
|
|
CNTG
65
DELISTED
Centogene N.V. Common Shares
CNTG
| $3.57M | 0.12% |
2,377,150
| – | – |
|
|
BPMC
66
DELISTED
Blueprint Medicines
BPMC
| $3.55M | 0.12% |
56,171
| – | – |
|
67
Zymeworks
ZYME
$1.07B
| $3.54M | 0.12% |
409,839
+3,512
| +0.9% | +$30.3K |
|
68
Arrowhead Research
ARWR
$3.84B
| $3.47M | 0.12% |
97,168
+20,960
| +28% | +$747K |
|
69
Vera Therapeutics
VERA
$1.47B
| $3.37M | 0.12% |
+209,700
| New | +$3.37M |
|
70
Bio-Rad Laboratories Class A
BIO
$7.8B
| $3.27M | 0.11% |
8,636
-9,706
| -53% | -$3.68M |
|
71
Immatics
IMTX
$662M
| $3.1M | 0.11% |
268,211
| – | – |
|
72
Gossamer Bio
GOSS
$587M
| $2.84M | 0.1% |
2,363,170
| – | – |
|
73
Prothena Corp
PRTA
$452M
| $2.83M | 0.1% |
41,508
| – | – |
|
|
ALLK
74
DELISTED
Allakos
ALLK
| $2.77M | 0.1% |
635,023
| – | – |
|
75
Adaptive Biotechnologies
ADPT
$1.96B
| $2.46M | 0.09% |
366,230
| – | – |
|